RESPONSE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
J Natl Cancer Inst
.
2000 Aug 2;92(15):1273.
doi: 10.1093/jnci/92.15.1273.
Authors
GN Hortobagyi
1
,
AU Buzdar
Affiliation
1
Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston.
PMID:
10922419
DOI:
10.1093/jnci/92.15.1273
No abstract available